Patents by Inventor Lee Alan Henderson

Lee Alan Henderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SINGLE CHAIN INTRABODIES THAT ALTER HUNTINGTIN MUTANT DEGRADATION
    Publication number: 20220064269
    Abstract: Compositions and methods of use are provided for intrabodies that bind and alter the effects of poly-glutamate protein aggregation in poly-glutamate associated diseases, such as in Huntington's disease. Intrabodies are provided that prevent poly-glutamate aggregation, gene dysregulation, and negative effects of Huntington's disease.
    Type: Application
    Filed: July 23, 2021
    Publication date: March 3, 2022
    Inventors: Lee Alan Henderson, Irene Alexandra Amaro
  • Single chain intrabodies that alter Huntingtin mutant degradation
    Patent number: 11072650
    Abstract: Compositions and methods of use are provided for intrabodies that bind and alter the effects of poly-glutamate protein aggregation in poly-glutamate associated diseases, such as in Huntington's disease. Intrabodies are provided that prevent poly-glutamate aggregation, gene dysregulation, and negative effects of Huntington's disease.
    Type: Grant
    Filed: February 20, 2018
    Date of Patent: July 27, 2021
    Assignee: Vybion, Inc.
    Inventors: Lee Alan Henderson, Irene Alexandra Amaro
  • Single Chain Intrabodies that Alter Huntingtin Mutant Degradation
    Publication number: 20180319874
    Abstract: Compositions and methods of use are provided for intrabodies that bind and alter the effects of poly-glutamate protein aggregation in poly-glutamate associated diseases, such as in Huntington's disease. Intrabodies are provided that prevent poly-glutamate aggregation, gene dysregulation, and negative effects of Huntington's disease.
    Type: Application
    Filed: February 20, 2018
    Publication date: November 8, 2018
    Inventors: Lee Alan Henderson, Irene Alexandra Amaro
  • Single chain intrabodies that alter huntingtin mutant degradation
    Patent number: 9932394
    Abstract: Compositions and methods of use are provided for intrabodies that bind and alter the effects of poly-glutamate protein aggregation in poly-glutamate associated diseases, such as in Huntington's disease. Intrabodies are provided that prevent poly-glutamate aggregation, gene dysregulation, and negative effects of Huntington's disease.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: April 3, 2018
    Assignee: Vybion, Inc.
    Inventors: Lee Alan Henderson, Irene Alexandra Amaro
  • Single Chain Intrabodies that Alter Huntingtin Mutant Degradation
    Publication number: 20170044241
    Abstract: Compositions and methods of use are provided for intrabodies that bind and alter the effects of poly-glutamate protein aggregation in poly-glutamate associated diseases, such as in Huntington's disease. Intrabodies are provided that prevent poly-glutamate aggregation, gene dysregulation, and negative effects of Huntington's disease.
    Type: Application
    Filed: June 4, 2015
    Publication date: February 16, 2017
    Inventors: Lee Alan Henderson, Irene Alexandra Amaro